MedTrace Logo

The Need for Luteal Support in NC-FET

NCT01483365 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2014-06-17

No results posted yet for this study

Summary

The investigators are going to examine prospectively the need of luteal support after NC-FET.

Conditions

  • Abnormal Menstrual Cycle

Interventions

DRUG

Vaginal tablet Endometrin twice a day

Endometrin 100 mg twice a day

Sponsors & Collaborators

  • Wolfson Medical Center

    lead OTHER_GOV

Principal Investigators

  • David Levran, M.D · IVF Unit, Department of Obstetrics and Gynecology,Wolfson Medical Center . Holon, Israel

Study Design

Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01483365 on ClinicalTrials.gov